Analisis Cost Of Illness Drug Reaction With Eosinophilia Systemic Symptoms Di RSUP Dr.Sardjito Yogyakarta

Vicryanto Halid, Dyah Aryani Perwitasari, Sri Awalia Febriana

Abstract


ABSTRAK

 

Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) adalah reaksi alergi kulit dengan demam, kenaikan eosinofil darah dan komplikasi organ. Sulitnya diagnosa dan lama terapi serta berpotensi kekambuhan membuat DRESS menjadi masalah karena mempengaruhi ekonomi. Cost of illness (COI) merupakan analisis menentukan beban ekonomi penyakit yang terdiri dari beberapa perspektif. Penelitian ini bertujuan mengetahui total COI dari perspektif Rumah sakit berdasarkan jenis DRESS, jenis obat, dan jumlah obat penyebab DRESS. Penelitian non-experimental dengan desain cross-sectional retrospektif. Subyek penelitian 21 pasien. Parameter biaya komponen biaya medis langsung yaitu biaya instalasi gawat darurat, pengobatan, monitoring, penunjang dan rawat jalan. Hasil analisis data berupa median (range). Median total COI DRESS dengan komplikasi organ adalah Rp.13.194.963 dan Rp.10.123.495 untuk pasien DRESS tanpa komplikasi organ. Antibiotik menjadi obat penyebab DRESS terbanyak (55,55%) dengan range total biaya tertingginya Rp.53.576.350. Kesimpulan: Total COI DRESS di RSUP Dr.Sardjito tahun 2014-2018 satu pasien adalah Rp.13.546.700.

Kata Kunci: Drug Reaction with Eosinophilia and Systemic Symptom, Cost OF illness, biaya medis langsung, komplikasi organ, perspektif Rumah sakit.

 

 

ABSTRACT

 

Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) are allergic skin reactions with fever, elevated blood eosinophils and organ complications. Difficult diagnosis and duration of therapy and potential recurrence make DRESS a problem because it affects the economy. Cost of illness (COI) is an analysis determining the economic burden of a disease consisting of several perspectives. This study aims to determine the total COI from the perspective of the hospital based on the type of DRESS, the amount and type of causative drug of DRESS. Non-experimental research with a retrospective cross-sectional design. Study subjects 21 patients. The cost parameters of the direct medical component costs are the costs of the emergency department, treatment, monitoring, support and outpatient care. The results of data analysis are in the form of a median (range). Results: The total median of COI DRESS with organ complications was Rp.13,194,963 and Rp.10,123,495 for DRESS patients without organ complications. Antibiotics became the most common drug causing DRESS (55.55%) with the highest total cost range of Rp.53,576,350. Conclusion: Total COI DRESS at Dr.Sardjito General Hospital in 2014-2018 one patient was Rp.13,546,700.

 

Keywords: Drug Reaction with Eosinophilia and Systemic Symptom, Cost of Illness, direct medical costs, organ complications, perspective of the hospital.

Full Text:

PDF

References


Abhishek De., Murlidhar Rajagopalan., Aarti Sarda., Sudip Das., and P. B.,2018, Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature, Indian Journal Dermatology, 63, pp. 30–40. doi: 10.4103/ijd.IJD_582_17.

Amalia, R., 2017, Analisis Efektivitas Direct Medical Cost Pengobatan Pasien Demam Tifoid Anak Menggunakan Seftriakson Dan Sefotaksim di RSUD DR.M.M. Dunda Limboto Tahun 2016,Skripsi. Universitas Negeri Gorontalo, Gorontalo.

Andayani, T. M.,2013,Farmakoekonomi : Prinsip Dan Metodologi. Pertama. Yogyakarta: Bursa Ilmu

Bootman, J.L., McGhan, W.F., dan Towssend, R. J., 2005,Principles of Pharmacoeconomics. Edisi III. Edited by H. W. B. Company. USA.

Byford, S., Torgerson, D. J., and Raftery, J., 2000, Economic Note: Cost of illness studies, Bmj, 320(7245), pp. 1335–1335. doi: 10.1136/bmj.320.7245.1335

Fong, C. Y., 2016, Sulthiame-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, European Journal of Paediatric Neurology, 20(6), pp. 957–961. doi: 10.1016/j.ejpn.2016.07.023.

James, J., 2018, Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to furosemide: Case report and review of literature, American Journal of Case Reports, 19, pp. 163–170. doi: 10.12659/AJCR.907464.

Musette, P., and Janela, B., 2017, New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology, Frontiers in Medicine, 4(December). doi: 10.3389/fmed.2017.00179.

Roy Akur P., Rengganis, I., 2016, Pendekatan Diagnosis dan Tata Laksana Alergi Obat Approach to Diagnosis and Treatment of Drug Allergy, Penyakit Dalam Indonesia, 3(1), pp. 45–52

Tarricone, R., 2006, Cost-of-illness analysis. What room in health economics?, Health Policy, 77(1), pp. 51–63. doi: 10.1016/j.healthpol.2005.07.016

Vanini, A., Hutomo, M., 2010, Manifestasi Klinis Sindroma DRESS (Drug Reaction with Eosinophilia and Systemic Symptom) (Clinical Manifestation of DRESS ( Drug Reaction with Eosinophilia and Systemic Symptom) Syndrome)

Wolfson, A.R., Li Zhou., Yu Li., Neelam A, Phadke., Ohn A, Chow., Kimberly. G. B., 2018,Dress Syndrome Cases In The Us: Rare, Morbid, And Costly, The Journal of Allergy and Clinical Immunology: In Practice is an official journal of the AAAAI, focusing on practical information for the practicing clinician. Available at: https:// www.aaaai.org/global/latest-research-summaries/New-Research-from-JACI-In-Practice/dress.

Yi-Chun, Chen, MD., Hsein-Ching Chiu, MD., Chia-Yu Chu, MD., P., 2019, Reaksi Obat Dengan Eosinofilia dan Gejala Sistemik, 146(12), pp. 1373–1379.




DOI: http://dx.doi.org/10.20527/jps.v7i1.8073

Article Metrics

Abstract view : 49 times
PDF - 53 times

Refbacks

  • There are currently no refbacks.


Jurnal Pharmascience Published BY:

Program Studi Farmasi Universitas Lambung Mangkurat

Jurnal Pharmascience is indexed by:


 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.